跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 173,726 条关于
“RAS(ON) inhibitors”
全部
173,726
临床试验
132,730
药物
3,849
机构
1,022
资讯
36,125
上个月
BeOne Medicines and Revolution Medicines Forge Multi-Part Collaboration to Advance RAS(ON) Inhibitors for RAS-Addicted Cancers
2年前
Revolution Medicines' RAS(ON) Inhibitors Show Promise in Lung and Pancreatic Cancers
去年
Revolution Medicines and Summit Therapeutics Launch Clinical Collaboration to Test RAS Inhibitor Combinations with Bispecific Antibody
4个月前
BeiGene and Revolution Medicines Forge Strategic Partnership to Bring Breakthrough Pancreatic Cancer Therapy to Asia
11个月前
Revolution Medicines Appoints Alan Sandler as Chief Development Officer to Advance RAS-Targeted Cancer Pipeline
去年
Revolution Medicines Secures $2 Billion Funding Deal with Royalty Pharma for RAS Cancer Drug Development
去年
Adlai Nortye to Showcase Novel Cancer Immunotherapy and RAS Inhibitor at AACR 2025
去年
Tango Therapeutics' PRMT5 Inhibitor TNG462 Shows Promise in Early Trials, Combination Studies Planned
2年前
RAS Inhibitors: No Clear Advantage to Stopping or Continuing Before Noncardiac Surgery
6个月前
Quanta Therapeutics' Direct KRAS Inhibitors Show Promise Against Resistance to Pan-RAS Tri-Complex Therapies
第 1 页,共 3613 页
上一页
下一页